Prediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging
HPB · 2024
DOI: 10.1016/j.hpb.2024.02.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2024. Verfasst von Johannes C Lauscher und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Visceral Surgery, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany. Hauptthemen laut MEDLINE: Hepatectomy, Gadolinium DTPA, Contrast Media, Magnetic Resonance Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Physicians' Services Inc Foundation.
Abstract (Originalsprache)
BACKGROUND: Approximately 15% of patients experience post-hepatectomy liver failure after major hepatectomy. Poor hepatocyte uptake of gadoxetate disodium, a magnetic resonance imaging contrast agent, may be a predictor of post-hepatectomy liver failure. METHODS: A retrospective cohort study of patients undergoing major hepatectomy (≥3 segments) with a preoperative gadoxetate disodium-enhanced magnetic resonance imaging was conducted. The liver signal intensity (standardized to the spleen) and the functional liver remnant was calculated to determine if this can predict post-hepatectomy liver failure after major hepatectomy. RESULTS: In 134 patients, low signal intensity of the remnant liver standardized by signal intensity of the spleen in post-contrast images was associated with post-hepatectomy liver failure in multiple logistic regression analysis (Odds Ratio 0.112; 95% CI 0.023-0.551). In a subgroup of 33 patients with lower quartile of functional liver remnant, area under the curve analysis demonstrated a diagnostic accuracy of functional liver remnant to predict post-hepatectomy liver failure of 0.857 with a cut-off value for functional liver remnant of 1.4985 with 80.0% sensitivity and 89.3% specificity. CONCLUSION: Functional liver remnant determined by gadoxetate disodium-enhanced magnetic resonance imaging is a predictor of post-hepatectomy liver failure which may help identify patients for resection, reducing morbidity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General and Visceral Surgery, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany.
- Division of Surgical Oncology, Rush University Medical Center 1725 W Harrison St, Chicago, Illinois, 60612 USA.
- Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Toronto ON M4N 3M5, Canada.
- Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin.
- Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
- University Hospital Edouard Herriot, France.
Förderung
- Physicians' Services Inc Foundation
Zitieren
APA
Lauscher, J. C., Dixon, M. E. B., Jada, G., Afshin, M., Neumann, K., Cheung, H., Martel, G., Hallet, J., Coburn, N., Law, C., Milot, L., & Karanicolas, P. J. (2024). Prediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging. HPB. https://doi.org/10.1016/j.hpb.2024.02.012
Vancouver
Lauscher JC, Dixon MEB, Jada G, Afshin M, Neumann K, Cheung H, et al. Prediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging. HPB. 2024. doi:10.1016/j.hpb.2024.02.012
BibTeX
@article{Lauscher2024,
author = {Lauscher, Johannes C and Dixon, Matthew E B and Jada, George and Afshin, Mariam and Neumann, Konrad and Cheung, Helen and Martel, Guillaume and Hallet, Julie and Coburn, Natalie and Law, Calvin and Milot, Laurent and Karanicolas, Paul J},
title = {Prediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging},
journal = {HPB},
year = {2024},
doi = {10.1016/j.hpb.2024.02.012}
}
EUVIMED